212 related articles for article (PubMed ID: 29479832)
61. Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis.
Gatti D; Viapiana O; Idolazzi L; Fracassi E; Ionescu C; Dartizio C; Troplini S; Kunnathully V; Adami S; Rossini M
Bone; 2014 Oct; 67():189-92. PubMed ID: 25003812
[TBL] [Abstract][Full Text] [Related]
62. [Monoclonal antibodies to sclerostin for the treatment of osteoporosis].
Soen S
Clin Calcium; 2013 Jun; 23(6):884-9. PubMed ID: 23719502
[TBL] [Abstract][Full Text] [Related]
63. Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin.
Gatti D; Viapiana O; Adami S; Idolazzi L; Fracassi E; Rossini M
Bone; 2012 Mar; 50(3):739-42. PubMed ID: 22178539
[TBL] [Abstract][Full Text] [Related]
64. [Osteoporosis in men].
Legrand E; Hoppé E; Bouvard B; Audran M
Rev Prat; 2012 Feb; 62(2):193-7. PubMed ID: 22408860
[TBL] [Abstract][Full Text] [Related]
65. Review article: non-alcoholic fatty liver disease and osteoporosis--clinical and molecular crosstalk.
Yilmaz Y
Aliment Pharmacol Ther; 2012 Aug; 36(4):345-52. PubMed ID: 22730920
[TBL] [Abstract][Full Text] [Related]
66. A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density.
Recker RR; Benson CT; Matsumoto T; Bolognese MA; Robins DA; Alam J; Chiang AY; Hu L; Krege JH; Sowa H; Mitlak BH; Myers SL
J Bone Miner Res; 2015 Feb; 30(2):216-24. PubMed ID: 25196993
[TBL] [Abstract][Full Text] [Related]
67. Skeletal morbidity in inflammatory bowel disease.
van Hogezand RA; Hamdy NA
Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
[TBL] [Abstract][Full Text] [Related]
68. Sclerostin and CKD-MBD.
Schiavi SC
Curr Osteoporos Rep; 2015 Jun; 13(3):159-65. PubMed ID: 25691219
[TBL] [Abstract][Full Text] [Related]
69. [Osteoporosis treatment].
Uebelhart B; Rizzoli R
Rev Med Suisse; 2006 Jan; 2(47):47-51. PubMed ID: 16465945
[TBL] [Abstract][Full Text] [Related]
70. Increased Serum 25(OH)D
Nakamura Y; Uchiyama S; Kamimura M; Ikegami S; Komatsu M; Kato H
Tohoku J Exp Med; 2017 Jul; 242(3):241-246. PubMed ID: 28740036
[TBL] [Abstract][Full Text] [Related]
71. [Anti-sclerostin antibodies].
Okazaki R
Clin Calcium; 2011 Jan; 21(1):94-8. PubMed ID: 21187600
[TBL] [Abstract][Full Text] [Related]
72. Osteoporosis.
Hay JE
Clin Liver Dis; 1998 May; 2(2):407-19, xi. PubMed ID: 15560040
[TBL] [Abstract][Full Text] [Related]
73. Osteodystrophy in chronic liver diseases.
Mansueto P; Carroccio A; Seidita A; Di Fede G; Craxì A
Intern Emerg Med; 2013 Aug; 8(5):377-88. PubMed ID: 22241574
[TBL] [Abstract][Full Text] [Related]
74. Bone Diseases in Patients with Chronic Liver Disease.
Jeong HM; Kim DJ
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480433
[TBL] [Abstract][Full Text] [Related]
75. Hepatic Osteodystrophy-Molecular Mechanisms Proposed to Favor Its Development.
Ehnert S; Aspera-Werz RH; Ruoß M; Dooley S; Hengstler JG; Nadalin S; Relja B; Badke A; Nussler AK
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137669
[TBL] [Abstract][Full Text] [Related]
76. AGA technical review on osteoporosis in hepatic disorders.
Leslie WD; Bernstein CN; Leboff MS;
Gastroenterology; 2003 Sep; 125(3):941-66. PubMed ID: 12949738
[No Abstract] [Full Text] [Related]
77. Bone changes in alcoholic liver disease.
González-Reimers E; Quintero-Platt G; Rodríguez-Rodríguez E; Martínez-Riera A; Alvisa-Negrín J; Santolaria-Fernández F
World J Hepatol; 2015 May; 7(9):1258-64. PubMed ID: 26019741
[TBL] [Abstract][Full Text] [Related]
78. Current understanding of osteoporosis associated with liver disease.
Nakchbandi IA; van der Merwe SW
Nat Rev Gastroenterol Hepatol; 2009 Nov; 6(11):660-70. PubMed ID: 19881518
[TBL] [Abstract][Full Text] [Related]
79. Bone disease in cholestatic liver disease.
Hay JE
Gastroenterology; 1995 Jan; 108(1):276-83. PubMed ID: 7806050
[TBL] [Abstract][Full Text] [Related]
80. [Liver cirrhosis and secondary osteoporosis].
Yang L; Yang CQ
Zhonghua Gan Zang Bing Za Zhi; 2021 Mar; 29(3):204-208. PubMed ID: 33902185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
